Do I need to declare Mounjaro on travel insurance?

Most UK travel insurers define any condition requiring a prescription as a ‘pre-existing medical condition’ — Mounjaro qualifies.
Non-disclosure can invalidate your policy entirely, not just the claim directly related to your treatment.
Declaring Mounjaro does not automatically mean a higher premium; many people pay the same or very close to it.
You also need to think practically: storing pens at 2–8 °C, carrying a translated prescription letter, and checking destination rules for injectable medicines all matter before you fly.

Yes, in most cases you should declare Mounjaro on your travel insurance. Tirzepatide is a prescription-only medicine for a pre-existing health condition, and nearly all UK travel insurers require you to disclose any ongoing prescription treatment when you take out or renew a policy. Failing to declare it could leave a claim unpaid — even for something unrelated to your weight or medication. The good news is that declaring it is straightforward, and for most people it makes little difference to the premium.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The decision to declare: what it turns on, and what to do about each factor

Why travel insurers treat Mounjaro as a pre-existing condition

Most UK travel insurance policies define a pre-existing medical condition as any illness, injury or health condition for which you are currently taking prescribed medication. Mounjaro (tirzepatide) is a prescription-only medicine licensed for weight management, which means the definition catches it, regardless of how well-controlled your weight is or whether you feel perfectly healthy. The NHS guidance on tirzepatide confirms it is dispensed on prescription only, reinforcing insurers’ right to classify it this way.

The consequence of not declaring is worth understanding clearly. If you have an accident abroad and a claims handler discovers an undisclosed prescription in your medical records, the insurer may treat the whole policy as misrepresented, not just any Mounjaro-related element. That means a ski injury, a cancelled flight or a hospital admission for something entirely separate could go uncompensated. The risk is disproportionate to any small saving you might make by staying quiet.

There is also a softer reason to declare. Mounjaro carries a small risk of gastrointestinal symptoms (nausea, vomiting, diarrhoea) that can worsen with travel stress, unfamiliar food or heat. If you needed hospital care abroad for severe dehydration tied to those symptoms, undisclosed treatment would complicate any claim immediately. Declaring puts you on solid ground from the start.

How declaring Mounjaro actually works in practice

When you get to the medical screening section of a travel insurance quote, you will be asked whether you are taking any prescribed medication or have any ongoing conditions. Answer yes, then name tirzepatide or Mounjaro. You may also be asked about the underlying condition being treated, typically obesity or a weight-related health condition such as high blood pressure or type 2 diabetes. Declare both the medicine and the condition.

Some insurers will ask a short series of follow-up questions: Is your condition stable? Have you been hospitalised in the past twelve months? Are you waiting for surgery? Most people on Mounjaro can answer those questions positively. The insurer then either covers the condition as standard, adds an exclusion for it, or applies a small loading to the premium. A loading is more common when there are multiple underlying conditions rather than for tirzepatide alone.

If you are considering how insurers handle the detail, our page on adding Mounjaro to your travel insurance walks through the screening process step by step. It is also worth reading your insurer’s policy wording before you travel rather than after, definitions of ‘pre-existing’ vary between providers, and some insurers like Admiral have published specific guidance on how they treat weight-loss medicines.

The practical side: travelling with Mounjaro pens

Declaration is only one part of the picture. Travelling with Mounjaro raises a few logistics that are worth sorting before your bags are packed, ideally not on a Monday morning when you’re already running late for a flight.

Mounjaro pens require refrigeration at 2–8 °C; once removed from the fridge they can be kept at room temperature only for the window stated in the Patient Information Leaflet, so check that carefully before you travel. On flights, pens should go in your carry-on luggage, hold temperatures are unpredictable and could damage the medicine. Carry a cool bag with an ice pack for transfers and excursions.

Many countries also require a letter from your prescriber confirming that you are carrying a prescription injectable medicine. A brief, signed letter on headed paper naming tirzepatide, the dose, and the fact that it is prescribed for you personally will satisfy most customs officials. If you are travelling outside the EU or to countries with stricter controlled-medicine rules, check the destination’s embassy requirements in advance, NHS England’s guidance on weight management injections notes that healthcare teams can support patients with documentation for travel. Our guide to using Mounjaro pens covers handling and storage in more detail.

Finally, think about disposal. A sharps container is a legal requirement in most countries for discarded needles. If you are travelling light, a small travel sharps container keeps you compliant without taking up much space in your bag.

What if you want to review your current Mounjaro supply before you go?

If you are due a repeat before you travel, it is sensible to plan ahead. Private treatment through a service like ours involves a clinical review before each repeat order, there are no auto-renewals and no assumption that the previous month’s supply will simply arrive again. Factor in time for that review when planning around a holiday, and remember that the free consultation can be started at any point. For anyone thinking about cost alongside everything else, our page on Mounjaro pricing in the UK explains what a legitimate private prescription typically includes. Questions about eligibility or your specific health picture are best directed to a prescriber, our clinical team reviews every consultation personally, and the FAQs cover the most common pre-travel queries we hear. If you want to explore how Mounjaro affects travel insurance premiums more broadly, that page goes into insurer behaviour in depth.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions